United Therapeutics reported $700K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Amarin AMRN:US USD 298.6M 3.94M
Ardelyx ARDX:US USD 19K 4K
Baxter International BAX:US USD 683M 0
Bayer BAYN:GR EUR 2.52B 0
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Emergent Biosolutions EBS:US USD 100K 0
Esperion Therapeutics ESPR:US USD 72K 7K
Gilead Sciences GILD:US USD 1000K 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Halozyme Therapeutics HALO:US USD 135K 3K
Insmed INSM:US USD 1.22M 18K
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Intra Cellular Therapies ITCI:US USD 9K 0
Lexicon Pharmaceuticals LXRX:US USD 189K 39K
Moderna Inc MRNA:US USD 38.7K 500
Omeros OMER:US USD 627K 0
Ptc Therapeutics PTCT:US USD 71K 0
Regeneron Pharmaceuticals REGN:US USD 100K 0
Sangamo Biosciences SGMO:US USD 1.62M 85K
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 185K 1000
Teva Pharmaceutical TEVA:IT USD 57M 19.86B
United Therapeutics UTHR:US USD 700K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0